Rafferty Asset Management, LLC
Position in MDGL — Madrigal Pharmaceuticals, Inc.
CIK 1389426
New York, NY
Position in MDGL
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$3,145,453
-$2,325,855 QoQ
Shares Held
5,858
-44.0% QoQ
Ownership
0.025%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#136
of 411 holders
Holding Since
Jun 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MDGL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Rafferty Asset Management, LLC holds $331,711,589 across 163 Biotechnology names. MDGL ranks #36 (0.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
65,798 | $32,683,840 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
38,534 | $24,027,490 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
55,332 | $16,656,591 | |
| 4 | MRNA |
Moderna, Inc.
|
111,906 | $7,836,777 | |
| 5 | INCY |
Incyte Corp
|
44,663 | $5,062,997 | |
| 6 | APGE |
Apogee Therapeutics, Inc.
|
33,369 | $4,429,067 | |
| 7 | ORKA |
Oruka Therapeutics, Inc.
|
43,110 | $4,102,778 | |
| 8 | KYMR |
Kymera Therapeutics, Inc.
|
35,287 | $4,046,360 |
All Filings in MDGL
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,145,453 | 5,858 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $5,471,308 | 10,452 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $6,132,040 | 10,530 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $8,583,821 | 18,715 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $7,424,667 | 24,533 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $9,904,439 | 29,902 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $10,220,764 | 33,123 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $9,470,105 | 44,624 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $10,202,866 | 36,418 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $9,591,275 | 35,917 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $9,972,246 | 43,099 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $6,618,970 | 45,323 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $7,220,136 | 31,256 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $6,815,985 | 28,135 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $30,589,447 | 105,390 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $4,284,205 | 65,921 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $2,230,432 | 31,160 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $4,541,680 | 46,287 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $3,096,992 | 36,547 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $2,509,874 | 31,456 | Shares | Sole | 2021-11-10 | |
| 2021-06-30 | $2,353,912 | 24,165 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $3,307,326 | 28,275 | Shares | Sole | 2021-05-10 | |
| 2020-12-31 | $775,299 | 6,974 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $1,247,377 | 10,506 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $861,039 | 7,603 | Shares | Sole | 2020-08-07 | |
| No filing history on record for this holder in this stock. | ||||||